Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE von Dooley, MA, Houssiau, F, Aranow, C, D’Cruz, DP, Askanase, A, Roth, DA, Zhong, ZJ, Cooper, S, Freimuth, WW, Ginzler, EM

Volltext

British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021 von O’Kane, D., McCourt, C., Meggitt, S., D’Cruz, D.P., Orteu, C.H., Benton, E., Wahie, S., Utton, S., Hashme, M., Mohd Mustapa, M.F., Exton, L.S.

Volltext

Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis von Davies, RJ, Sangle, SR, Jordan, NP, Aslam, L, Lewis, MJ, Wedgwood, R, D’Cruz, DP

Volltext

Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? von Ferreira, S., D'Cruz, D. P., Hughes, G. R. V.

Volltext

Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise von Tench, C. M., McCarthy, J., McCurdie, I., White, P. D., D'Cruz, D. P.

Volltext

Weight loss and improvements in fatigue in systemic lupus erythematosus: a controlled trial of a low glycaemic index diet versus a calorie restricted diet in patients treated with... von Davies, RJ, Lomer, MCE, Yeo, SI, Avloniti, K, Sangle, SR, D’Cruz, DP

Volltext

The prevalence and associations of fatigue in systemic lupus erythematosus von Tench, C. M., McCurdie, I., White, P. D., D'Cruz, D. P.

Volltext

Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative von Lampropoulos, C. E., Sangle, S., Harrison, P., Hughes, G. R. V., D'Cruz, D. P.

Volltext

Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients von Micheloud, D, Calderón, M, Caparrros, M, D’Cruz, D P

Volltext

Mycophenolate mofetil treatment in resistant myositis von Pisoni, C. N., Cuadrado, M. J., Khamashta, M. A., Hughes, G. R. V., D'Cruz, D. P.

Volltext

Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension von Sangle, S R, D’Cruz, D P, Jan, W, Karim, M Y, Khamashta, M A, Abbs, I C, Hughes, G R V

Volltext

Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome von Christodoulou, C., Sangle, S., D'Cruz, D. P.

Volltext

Prevalence of the antiphospholipid syndrome in primary systemic vasculitis von Rees, J D, Lança, S, Marques, P V, Gómez-Puerta, J A, Moco, R, Oliveri, C, Khamashta, M A, Hughes, G R V, D’Cruz, D P

Volltext

Anti-β2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome von Hamid, C, Norgate, K, D’Cruz, D P, Khamashta, M A, Arno, M, Pearson, J D, Frampton, G, Murphy, J J

Volltext

Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data von Barón, M A, Khamashta, M A, Hughes, G R V, D’Cruz, D P

Volltext

Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents von Karim, M. Y., Alba, P., Cuadrado, M.‐J., Abbs, I. C., D'Cruz, D. P., Khamashta, M. A., Hughes, G. R. V.

Volltext

Cardiac complications of Behcet’s disease von Jagadeesh, L. Yalakki, Wajed, J., Sangle, S. R., Carr-White, G., D’Cruz, D. P.

Volltext

Topical tacrolimus treatment in a patient with dermatomyositis von Lampropoulos, C E, D’ Cruz, D P

Volltext

Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study von Theodoridou, A, Bento, L, D’Cruz, D P, Khamashta, M A, Hughes, G R V

Volltext

Pyridoxine toxicity courtesy of your local health food store von Silva, C D, D’Cruz, D P

Volltext